BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 34478542)

  • 1. Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.
    Mallari RJ; Thakur JD; Barkhoudarian G; Eisenberg A; Rodriguez A; Rettinger S; Cohan P; Nieman L; Kelly DF
    J Clin Endocrinol Metab; 2022 Jan; 107(1):205-218. PubMed ID: 34478542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
    Carroll TB; Javorsky BR; Findling JW
    Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
    Erfe JM; Perry A; McClaskey J; Inzucchi SE; James WS; Eid T; Bronen RA; Mahajan A; Huttner A; Santos F; Spencer D
    J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
    Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
    J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive Diagnostic Strategy in ACTH-dependent Cushing's Syndrome.
    Frete C; Corcuff JB; Kuhn E; Salenave S; Gaye D; Young J; Chanson P; Tabarin A
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32594169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
    Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
    Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
    Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.
    Asuzu D; Chatain GP; Hayes C; Benzo S; McGlotten R; Keil M; Beri A; Sharma ST; Nieman L; Lodish M; Stratakis C; Lonser RR; Oldfield EH; Chittiboina P
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2179-2187. PubMed ID: 28323961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.
    Wang F; Catalino MP; Bi WL; Dunn IF; Smith TR; Guo Y; Hordejuk D; Kaiser UB; Laws ER; Min L
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e94-e102. PubMed ID: 33108450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease.
    Srinivasan L; Laws ER; Dodd RL; Monita MM; Tannenbaum CE; Kirkeby KM; Chu OS; Harsh GR; Katznelson L
    Pituitary; 2011 Dec; 14(4):312-7. PubMed ID: 21298507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cyclic Cushing's disease using late night salivary cortisol testing.
    Jahandideh D; Swearingen B; Nachtigall LB; Klibanski A; Biller BMK; Tritos NA
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):336-345. PubMed ID: 29873834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.
    Lindsay JR; Oldfield EH; Stratakis CA; Nieman LK
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2057-64. PubMed ID: 21508126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical diagnosis of Cushing's disease: Screening and confirmatory testing.
    Petersenn S
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101519. PubMed ID: 33757676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease.
    Esposito F; Dusick JR; Cohan P; Moftakhar P; McArthur D; Wang C; Swerdloff RS; Kelly DF
    J Clin Endocrinol Metab; 2006 Jan; 91(1):7-13. PubMed ID: 16234305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China.
    Zhang K; Shen M; Qiao N; Chen Z; He W; Ma Z; Shou X; Li S; Zhao Y; Pan L; Liu D; He M; Zhang Z; Li Y; Yao Z; Ye H; Wang Y
    Neurosurg Focus; 2020 Jun; 48(6):E7. PubMed ID: 32480378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.